INS and polycystic ovary syndrome: As such, the biological rationale underpinning the use of inositols as a potential therapeutic strategy for the clinical management of PCOS is derived from their insulin-mimetic properties to reduce postprandial blood glucose, with glucose metabolism shifted toward glycogen synthesis by DCI and glucose catabolism by MYO [50,51].